Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 745 | 270 | 22 | 109 | 448 |
| Cost of Goods | 31 | 24 | 10 | 13 | 23 |
| Gross Profit | 714 | 246 | 12 | 96 | 425 |
| Operating Expenses | 5,307 | 5,807 | 3,626 | 4,831 | 3,515 |
| Operating Income | -4,562 | -5,537 | -3,604 | -4,722 | -3,067 |
| Other Income | 174 | 183 | 203 | 83 | -17 |
| Pre-tax Income | -4,388 | -5,354 | -3,401 | -4,639 | -3,084 |
| Income Tax | 120 | 30 | N/A | 8 | 1 |
| Net Income Continuous | -4,508 | -5,384 | -3,401 | -4,647 | -3,085 |
| Net Income | $-4,508 | $-5,384 | $-3,401 | $-4,647 | $-3,085 |
| EPS Basic Total Ops | -0.15 | -0.15 | -0.11 | -0.18 | -0.14 |
| EPS Basic Continuous Ops | -0.15 | -0.16 | -0.11 | -0.18 | -0.14 |
| EPS Diluted Total Ops | -0.15 | -0.15 | -0.11 | -0.18 | -0.14 |
| EPS Diluted Continuous Ops | -0.15 | -0.16 | -0.11 | -0.18 | -0.14 |
| EBITDA(a) | $-4,532 | $-5,508 | $-3,623 | $-4,662 | $-3,050 |